论文部分内容阅读
Objectives Increasing intestinal microbiota has been proposed as a basic pathogenic event in Crohns disease.Our aim was to study intestinal flora in active Crohns disease before and after treatment with infliximab (IFX) directed against tumor necrosis factor (TNF) to investigate whether the abnormal microflora persists after control of inflammation.